SITC Archive Library

Back to Library

SITC 2018 Annual Meeting: Concurrent Session 100: FDA and SU2C Update Session 

12-12-2018 11:37

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 100: FDA and SU2C Update Session" during the SITC 2018 Annual Meeting on November 9, 2018. Available here are the presentation slides and video from the session.

33rd Annual Meeting Organizers

  • Crystal L. Mackall, MD – Stanford University
  • Naiyer A. Rizvi, MD – Columbia University Medical Center
  • Krista M. Rubin, MS, FNP-BC – Massachusetts General Hospital
  • Dario A. A. Vignali, PhD – University of Pittsburgh

Program Summary

The Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#Lymphoma#Leukemia#PresentationSlides#Video#AnnualMeeting#SITC
#AdoptiveCellTherapy#TherapeuticAntibodies#Clinician#Oncologist
#Researcher#2018#RegisteredNurse#Pharmacist​

Statistics
0 Favorited
131 Views
2 Files
0 Shares
101 Downloads

​
Attachment(s)
Download All
pdf file
Cell and Gene Therapy" - Presentation Slides   812 KB   1 version
Uploaded - 12-12-2018
Meeting: SITC 33 Annual Meeting: Session 100: FDA and SU2C Update Session; Presenter: Raj Puri, MD, PhD – Food & Drug Administration; Date: November 9, 2018
 
Download
mp4 file
Cell and Gene Therapy" - Video   232.42 MB   1 version
Uploaded - 12-12-2018
Meeting: SITC 33 Annual Meeting: Session 100: FDA and SU2C Update Session; Presenter: Raj Puri, MD, PhD – Food & Drug Administration; Date: November 9, 2018
 
Download